Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study found that more than one-quarter of patients experienced persistent symptoms up to 24 months after mild COVID-19, suggesting long-term effects even in less severe cases.

This study reviewed recent literature on Long COVID, examining cardiopulmonary, dermatological, neurological, and rheumatological symptoms and identifying risk factors like severe initial infection, comorbidities, and lack of prior vaccination.

This study found that zinc acetate hydrate may improve fatigue and hair loss symptoms in post-COVID-19 patients.

This study found that late-onset hypogonadism is relatively common in male patients with long COVID, even among those under 50, and serum free testosterone measurement can help reveal this condition.

This study reports a case where a young male experienced improved hair condition following individualized homeopathic treatment and integrative therapy after hair thinning post-COVID-19 infection, suggesting potential benefits of non-invasive approaches at Dr Batra’s.

This study explored the connections between Covid-19 and hair loss issues like telogen effluvium and alopecia areata, highlighting the virus's potential trigger effect and underscoring the importance of comprehensive post-Covid-19 treatment strategies that consider immune, psychological, and hair cycle factors.

This study observed a variety of skin conditions related to COVID-19 and its vaccines in a Brazilian setting, classifying them into five categories, including peri-infectious reactions and vaccine-related adverse effects, to aid physicians managing similar cases.

This study observed that COVID-19 patients in Thailand infected with the Delta variant were more likely to develop pneumonia and certain post-infection conditions, while Omicron infections were associated with milder symptoms like sore throat and congestion.

This study found that women with post-COVID alopecia showed a diffuse telogen effluvium pattern and distinct trace element imbalances, such as reduced copper and increased selenium levels, helping differentiate this condition from androgenetic alopecia.

This study observed that a significant number of hospitalized COVID-19 patients in Mato Grosso State, Brazil, experienced persistent symptoms like fatigue, memory problems, and hair loss 6 and 12 months after discharge, with higher prevalence among older, lower-income patients and those with pre-existing conditions.

This narrative review explores mechanisms linking COVID-19 with hair loss, highlighting how cytokine-mediated inflammation, androgen-regulated TMPRSS2 expression, and direct follicular injury contribute to the condition. It suggests that vitamin D could potentially mitigate this hair loss by suppressing inflammation and viral entry, warranting further research.

This review discusses immunomodulatory formulations to address post-COVID conditions and reports no new clinical findings.

This literature review observed that patients with thrombophilic conditions may experience distinct and more severe Long COVID symptoms, potentially linked to chronic hypercoagulation post-COVID-19 infection.

This case report discusses a new onset of alopecia areata following reinfection with COVID-19, suggesting a potential link between COVID-19 infection and this hair loss condition.

This source outlines the complex and widespread impact of post-COVID syndromes, highlighting persistent symptoms and the need for interdisciplinary management to address these conditions and their socioeconomic implications as the world moves beyond the pandemic.

In this study, nearly two-thirds of Saudi adults reported experiencing hair loss following COVID-19 infection or vaccination, with female sex and nutritional deficiencies identified as significant correlates for this condition.

This report describes two cases where a viral vector COVID-19 vaccine was associated with the recurrence of cutaneous lymphoma conditions that had been in remission.

This study found that many conditions in patients with COVID-19 were significantly increased compared to controls, with specific phenotypes identified across different demographic and diagnostic attributes.

This study examines how conditions like PSSD, Long COVID, and ME/CFS form a "Post-Exposure Syndromes" family, initiated by transient exposures but persisting due to complex state-space dynamics, and suggests improving pharmacovigilance to better address and understand these persistent syndromes.

In this study, a community pharmacy-based intervention in Serbia was associated with significant improvements in clinical symptoms for patients with post-COVID syndrome.

A woman's complete hair loss condition improved after recovering from COVID-19.

This presentation argues that post-exposure syndromes like PSSD and Long COVID form a coherent group of conditions driven by complex interactions in high-dimensional state spaces rather than singular molecular pathways.

This article presents a case of telogen effluvium, a condition causing hair loss, occurring three months after a COVID-19 infection.

This study reviews skin issues caused by COVID-19 and related measures, concluding that cosmeceuticals, positioned between cosmetics and pharmaceuticals, are widely recommended for managing these conditions unless they are severe.

This publication discusses the potential mechanisms behind telogen alopecia as a dermatological manifestation of post-COVID-19 syndrome and reports no new clinical results.

In this study, 41% of participants reported experiencing alopecia post-COVID-19, with notable associations found between the condition and female sex, azithromycin use, and symptoms like fatigue and post-infection skin irritation.

In this study, a case of post-COVID telogen effluvium was reported in which fever and stress following COVID-19 triggered temporary hair loss, and topical treatment showed positive results in improving this condition.

This study found that female COVID-19 survivors were more likely than males to experience multiple long-term post-COVID symptoms, including fatigue, pain, hair loss, and mood disorders.

This article reviews the potential causes of post-COVID telogen effluvium, attributing it to both inflammatory responses to SARS-CoV-2 and psychosocial stress, and suggests that hair recovery may occur without specific treatment.

This case report describes a 79-year-old woman who developed alopecia universalis shortly after recovering from COVID-19, highlighting its relapsing nature and the challenges in long-term disease management.